Debiopharm International SA

Debiopharm International SA

Debiopharm International SA

Overview
Date Founded

1979

Headquarters

5-7, chemin Messidor,Lausanne, Vaud 1002

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

Website

http://www.debiopharm.com/

In The News
PR Newswire
September 22, 2020
Debiopharm Honored as a 2020 Swiss Biotech Success Story Winner For Outstanding Achievements Over 40 Years
PR Newswire
June 10, 2020
Debiopharm's Novel Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders; Takeda will pursue the development of a novel preclinical narrow spectrum microbiome remodeling program, to treat diseases related to dysb
PR Newswire
June 9, 2020
Debiopharm partners with Verity Pharmaceuticals for the exclusive US commercialization of Trelstar® for Prostate Cancer
PR Newswire
May 26, 2020
Acquisition of Debiopharm's Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention; - Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved
PR Newswire
March 25, 2020
Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-Licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Bertrand Ducrey

Chief Executive Officer

Vanessa Currat

General Counsel

Frédéric Lévy

Director, Head of Search & Evaluation & Scientific Innovation

Stéphane Bernard

Director, Project Management Office

Fabien Sebille

Director, Business Development, Licensing, Marketing & Communication

Peggy Lipp

Director, Regulatory Affairs, Business Intelligence & Market Access

Daniel Brandt

Director, Quality Management & Documentation

Manuela Perraudin

Director, Human Resources

Alexandre Maret

Director-Finance & Administration

Christine Deuschel Cornioley

Senior Vice President, Portfolio & Project Management

Trending People
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
United States Department of Agriculture
USDA relocations curtail ag research, farmer confidence - The Independent UK
Democratic Party
Rising Mich. Dem star's 2 paychecks could pose a conflict - Detroit Free Press
Supreme Court of the United States
Hamline Law School: New Course at Mitchell Hamline Focuses on Transgender Rights... - Targeted News Service
Trending Organizations
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
United States Department of Agriculture
USDA relocations curtail ag research, farmer confidence - The Independent UK
Democratic Party
Rising Mich. Dem star's 2 paychecks could pose a conflict - Detroit Free Press
Supreme Court of the United States
Hamline Law School: New Course at Mitchell Hamline Focuses on Transgender Rights... - Targeted News Service
Paths to Debiopharm International SA
Potential Connections via
Relationship Science
You
Debiopharm International SA
Recent Transactions
Details Hidden

Meridian Bioscience, Inc. purchases GenePOC, Inc. from Debiopharm International SA

Details Hidden

Debiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Transaction Advisors
Legal Advisor
Fasken Martineau DuMoulin LLP

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Legal Advisor
Gide Loyrette Nouel LLP

Advised onGecina purchases Eurosic SAS

Legal Advisor
E. Scott Conover

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Legal Advisor
Sylvie Bourdeau

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Attorney
Talia Markarian

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Clients
Knight Therapeutics, Inc.

Knight Therapeutics Inc engages in acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. Its products include ILUVIEN, Nerlynx, Probuphine, Movantik, and Neuragen. The company was founded by Jonathan R. Goodman on November 1, 2013 and is headquartered in Montreal, Canada.
Investments
Details Hidden
GenePOC, Inc.

GenePOC, Inc. develops rapid molecular devices to detect genes at point-of-care. Its product includes an integrated portable instrument for the prevention and early detection of infectious diseases based on a centripetal technology platform. Its product also includes GenePOC disposable, a device for performing nucleic acid-based diagnostics at POC. The company’s products are also used for infectious disease, rapid food microbiology, and human pharmacogenetic testing applications. The company was founded by Michel G. Bergeron in 2007 and is headquartered in Quebec, Canada.

Details Hidden
Diagnoplex SA

Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland.

Details Hidden
Agendia NV

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Suppliers
Immunogen Inc. Medical Support Services | Waltham, MA

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Debiopharm International SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Debiopharm International SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Debiopharm International SA.